Top Biotechnology & Medical Research stocks in Australia

Researchers and developers of biotechnology based drugs and therapies as well as medical devices and procedures that are at an early (non-commercial) stage.

Name
Market Cap
Price to Earnings
TTM
Dividend Yield
% TTM
au flag iconTLXTelix PharmaceuticalsAU$3.82bnn/an/a
au flag iconMSBMesoblastAU$2.72bnn/an/a
au flag iconCU6Clarity PharmaceuticalsAU$1.42bnn/an/a
au flag iconPYCPYC TherapeuticsAU$1.32bnn/an/a
au flag iconRACRacura OncologyAU$392.38mn/an/a
au flag iconCGSCogstateAU$368.84m24.720.87%
au flag iconDXBDimerixAU$210.14mn/an/a
au flag iconTTXTetratherixAU$209.38mn/an/a
au flag iconNYRNyradaAU$125.28mn/an/a
au flag iconILAIsland PharmaceuticalsAU$121.07mn/an/a
au flag iconBXNBioxyneAU$120.17m13.99n/a
au flag iconACWActinogen MedicalAU$117.92mn/an/a
au flag iconPARParadigm BiopharmaceuticalsAU$111.41mn/an/a
au flag iconALAArovella TherapeuticsAU$88.89mn/an/a
au flag iconATHAlterity TherapeuticsAU$87.00mn/an/a
au flag iconLTPLtr PharmaAU$79.92mn/an/a
au flag iconCYPCynata TherapeuticsAU$73.61mn/an/a
au flag iconRHYRhythm BiosciencesAU$70.77mn/an/a
au flag iconIMMImmutepAU$66.32mn/an/a
au flag iconGD8GO-DX (Aust)AU$61.94mn/an/a